REYON Pharmaceutical (representative directors Sunok Jeong, Yonghwan Yoo) announced on the 24th that it has signed a comprehensive MOU on the development of natural medicines with 'FINZELBERG', a German company specializing in natural product Active Phytopharmaceutical Ingredients (API), as part of building a business portfolio to promote diverse growth in Germany.

An official at REYON Pharmaceutical said, "FINZELBERG is a company specializing in natural API that has accumulated expertise and production experience related to medicinal plant extracts with a history of more than 140 years since its establishment in 1875. It is supplying more than 800 different extracts and health functional foods produced by processing more than 100 different kinds of plants in various forms to more than 50 countries."

An official at REYON Pharmaceutical said, "FINZELBERG is a company specializing in natural API that has accumulated expertise and production experience related to medicinal plant extracts with a history of more than 140 years since its establishment in 1875. It is supplying more than 800 different extracts and health functional foods produced by processing more than 100 different kinds of plants in various forms to more than 50 countries."

Representative Yonghwan Yoo said, "Starting with the MOU, we plan to we will diversify our business areas and actively expand the market through domestic/export expansion as a natural drug manufacturing/development specialist." He went on to say, "As a co-developing business partner, we plan to conduct discussions on joint ventures to maximize synergy effects."

REYON Pharmaceutical, which is laying the groundwork for diverse growth this year, such as establishing a new technology business finance company and constructing a mass production plant for gene therapy products in Chungju, is in the spotlight as spectators anticipate how the company will grow and develop in the natural medicines market after singing an MOU with traditional European natural medicine API company, FINZELBERG.